Ergotamine-C

Generic name: Ergotamine-C
Pharmacotherapeutic group: Vascular headache suppressant & Ergot derivativeGhorse_Ergotamin_cTherapeutic indication: Treatment and prophylaxis of vascular headache such as migraine and cluster headache.
Dosage and Administration: Tablet 1mg of ergotamine tartrate and 100mg of caffeine.
Acute headache: Adult; Oral, 1 or 2 tabs at the start of the attack, followed by an additional 1 or 2 tabs at intervals of at least 30 min up to a total of  4 tabs/d. The total weekly dose should not exceed 6 tabs.
Pediatric 6 to 12 years: Oral, 1 tab initially, May be repeated one or two times, if necessary, up to a total of 3 tabs/d.
Cluster headache prophylaxis: Adult; Oral, 1 or 2 tabs one to three times a day, one or two hours prior to the time that attacks usually occur.  
Pediatric up to 6 years: Use is not recommended
Side effect: Cardiovascular effects, coronary vasospasm, chest pain, fast or slow heartbeat, localized edema, increase or decrease in blood pressure, rapid or weak pulse, cerebral ischemia, dryness of mouth, diarrhea, nausea or vomiting, peripheral vascular effects, mild and lasting 1 hour or less (cold fingers or toes, itching of skin, numbness or tingling of fingers or toes, weakness in the legs)
Information on the shelf life: 3 years



Valproate Sodium

Generic name: Valproate Sodium
Brand name: Orlept ®
Pharmacotherapeutic group: Anticonvulsant & AntimanicGhorse_Valproat_2
Therapeutic indication: Epilepsy (absence seizure, mixed seizure, complex partial seizure, myoclonic seizure, simple partial seizure, tonic-clonic seizure) & Bipolar disorder (manic episodes) & Prophylaxis migraine headaches
Dosage and Administration: Tablet 200mg
Anticonvulsant:
Adult:
Monotherapy: Oral; initially, 5 to 10mg/kg/day; the dosage being increased at       one-week intervals by 5 to 10mg/kg/day as needed and tolerated.
Polytherapy: Oral; initially, 10 to 30mg/kg/day; the dosage being increased at       one-week intervals by 5 to 10mg/kg/day as needed and tolerated.
If the total daily dose exceeds 250mg, it should be divided into two or more doses. The maximum recommended dosage is 60mg/kg/day.
Pediatric 1 to 12 years:
Monotherapy: Oral; initially, 15 to 45mg/kg/day; the dosage being increased at       one-week intervals by 5 to 10mg/kg/day as needed and tolerated.
Polytherapy: Oral, 30 to 100mg/kg/day
Side effect: Abdominal or stomach cramps, anorexia, change in menstrual periods, diarrhea, hair loss, indigestion, nausea and vomiting, trembling of hands and arms, unusual weight loss or gain, ataxia, constipation, dizziness, drowsiness,  headache, skin rash, unusual excitement, restlessness, irritability, increased in frequency of seizures, blurred vision
Information on the shelf life: 2 years



Citicoline

Generic name: CiticolineAmpule_Citicoline
Pharmacotherapeutic group: Colin and Cytidine derivative
Therapeutic indication: Cerebrovascular disorders (ischemic stroke) & Parkinsonism & Head injury
Dosage and Administration: Injection 250mg/2ml
IV or IM injection in doses of up to 1gr daily
Side effect: Insomnia, agitation, seizures, nausea or vomiting, headache, dizziness, anorexia, abdominal cramps, transit change in blood pressure
Information on the shelf life: 2 years





Calcium Carbonate Eff

Generic name: Calcium Carbonate Eff
Brand generic name: Calcium Carbonate Effervescent GhorseKalesium
Minoo®Pharmacotherapeutic group: Nutritional supplement & Electrolyte
Therapeutic indication: Hypocalcemia & Hyperphosphatemic & Calcium deficiency
Dosage and Administration: Effervescent tablet: 1250mg calcium carbonate (500mg of calcium ion). The measured dose is to be dissolved in a glass of cool water just prior to administration.
Adult males & females: 800-1200mg/d
Pregnant & breast-feeding females: 1200mg/d
Pediatric 4 to 10 years: 800 mg/d
Side effect: Renal calculi, hypercalcemic syndrome (Early symptoms: constipation, dryness of mouth, headache, increased thirst, irritability, loss of appetite, mental depression, metallic taste, tiredness or weakness. Late symptoms: confusion, drowsiness, high blood pressure, increased sensivity of eyes or skin to light, irregular fast or slow heartbeat, nausea and vomiting)
Information on the shelf life: 2 years





Calcium- Vitamin C Effervescent

Generic name: Calcium- Vitamin C EffervescentGhorse_Vitamin_c
Pharmacotherapeutic group: Nutritional supplement & Electrolyte
Therapeutic indication: Hypocalcemia & Calcium deficiency &
Vitamin C deficiency & Healing wounds
Dosage and Administration: Effervescent tablet: total of 260mg calcium ion & 500mg of Vit.C. The measured dose is to be dissolved in a glass of cool water just prior to administration.
Adult and Pediatric older than 12 years: 1 tab/day
Pediatric up to 12 years: half -one tab/day
Side effect: Gastrointestinal irritation (nausea, vomiting, constipation), stomach cramps, renal calculi, hypercalcemic syndrome (Early symptoms: constipation, dryness of mouth, headache, increased thirst, irritability, loss of appetite, mental depression, metallic taste, tiredness or weakness. Late symptoms: confusion, drowsiness, high blood pressure, increased sensivity of eyes or skin to light, irregular fast or slow heartbeat, nausea and vomiting)



Gripe Mixture

Generic name: Gripe Mixture                                                                                                 Sharbate_Grip
Brand name: Gripe Mixture®
Pharmacotherapeutic group: Gastrointestinal spasmolytic & ََAntiflatulent                   
Therapeutic indication: Treatment of colic in infants & Antigas & Antiflatulent            
Dosage and Administration: Syrup 120ml
Infant 1 to 6 months: 1 teaspoon as needed
Infant 6 months to 2 years: 2 teaspoons as needed
Pediatric older than 2 years: 2 to 3 teaspoons as needed
Side effect: May be allergic reaction
Information on the shelf life: 1 year







Diphenoxylate

Generic name: Diphenoxylate      Ghorse_Difnoxilat
Brand generic name: Minoo Diphenoxylate®
Pharmacotherapeutic group: Antidiarrheal
Therapeutic indication: Symptomatic treatment of acute and chronic diarrhea,
in adult Dosage and Administration: Tablet 2.5mg of diphenoxylate
hydrochloride and 0.025mg of atropine sulfate
Adult: oral, initial: 2 tabs/ three or four times a day
Maintenance: 2 tabs once a day
Pediatric 12 years and older: see usual adult dose
Pediatric up to 12 years: Use is not recommended
Side effect: Pancretitis, paralytic ileus or toxic megacolon, mild
anticholinergic effects (dryness of skin and mouth), CNS depression, confusion, headache, hyperthermia (flushing), numbness of hands or feet, skin rash or itching, swelling of the gums, increased sweating, muscle cramps, nausea or vomiting, shivering or trembling, stomach cramps
Information on the shelf life: 5 years